Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123316) titled 'SKIC-02 Injection for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: An Exploratory Study' on April 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Acute myeloid leukemia (AML)
Intervention:
Low dose trial group:SKIC-02 injection, 2 mg/dose, intravenous infusion on D0, D2, and D4
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-05-01
Target Sample Size: Low dose trial group:6;High dose experimental group:6;
Countries of Recruitment:
China
To know more, visit https://www.chictr.o...